ResMed (RMD) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $220.37 --0%
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Basic weighted average shares outstanding: 140.79M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.51, in-line with the analyst estimate of $1.51. Revenue for the quarter came in at $950.3 million versus the consensus estimate of $947.96 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
- Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
